Fungal Nail Infection Explained: What’s Actually Happening to Your Nail – and Why It’s Harder to Treat Than You Think

Fungal nail infection – medically called onychomycosis – is one of the most common nail conditions in the world, affecting approximately 10% of the global population. That figure rises to around 20% in adults over 60 and up to 50% in those over 70. Despite how common it is, it’s also one of the most undertreated conditions – partly because people dismiss it as cosmetic, partly because treatment is slow and requires commitment, and partly because the wrong treatments get used repeatedly without results.

This article covers what onychomycosis actually is, why nails are so susceptible to fungal infection, how to distinguish it from other nail conditions, and what the evidence shows about treatment – including why topical treatments often fail and when oral antifungals are necessary.

What Fungal Nail Infection Is

Onychomycosis is a fungal infection of the nail unit – affecting the nail plate, nail bed, and sometimes the surrounding skin. It’s most common in toenails (accounting for approximately 80% of cases) but also affects fingernails.

The condition is caused by three main groups of organisms:

Dermatophytes – the most common cause, responsible for approximately 90% of toenail infections. The primary culprit is Trichophyton rubrum, followed by Trichophyton interdigitale (formerly T. mentagrophytes). Dermatophytes are the same organisms that cause athlete’s foot (tinea pedis), ringworm (tinea corporis), and jock itch (tinea cruris).

Yeasts – primarily Candida species. More common in fingernail infections than toenail infections. More likely in people who frequently immerse their hands in water (healthcare workers, cooks, cleaners) and in immunocompromised individuals.

Non-dermatophyte moulds – less common, including Fusarium, Aspergillus, and Scopulariopsis species. More treatment-resistant than dermatophyte infections and may require different antifungal agents.

Why Nails Are Vulnerable

Nails create a uniquely difficult environment for the immune system to defend. The nail plate is a dense, hard keratin structure with minimal blood supply – meaning immune cells and systemically administered drugs reach the nail bed slowly and in low concentrations. Fungi can establish themselves in the nail keratin where immune surveillance is limited.

Several factors increase susceptibility:

• Age: Nail growth slows with age, circulation decreases, and cumulative trauma to nails accumulates over years. The elderly are disproportionately affected.
• Athlete’s foot (tinea pedis): Untreated fungal skin infection of the feet frequently spreads to the nails. This is one of the most important modifiable risk factors.
• Trauma: Repetitive minor nail trauma (from shoes, sports, or manual work) creates entry points for fungal invasion.
• Hyperhidrosis (excessive sweating): Creates a warm, moist environment that promotes fungal growth.
• Occlusive footwear: Shoes that create warmth and moisture around the feet.
• Diabetes: Peripheral vascular disease, immune dysfunction, and neuropathy (reducing awareness of trauma) all increase onychomycosis risk. Diabetic patients with onychomycosis also have increased risk of secondary bacterial infections.
• Immunosuppression: HIV, organ transplantation, and immunosuppressive medications significantly increase risk and severity.
• Family history: Genetic susceptibility to dermatophyte infections is documented – onychomycosis clusters in families beyond what shared environments explain.
• Swimming pools and communal showers: High-fungal-load environments where barefoot exposure is common.

What It Looks Like: Clinical Subtypes

Onychomycosis presents in several distinct patterns depending on how the fungus enters and spreads through the nail unit:

Distal and lateral subungual onychomycosis (DLSO) – the most common pattern. Infection begins at the free edge or side of the nail and spreads toward the base. The nail becomes thickened, discoloured (yellow, white, brown, or black), and the nail plate separates from the nail bed (onycholysis). Subungual debris accumulates under the nail.

White superficial onychomycosis (WSO) – fungus invades the surface of the nail plate directly, producing white, chalky, crumbling patches on the nail surface. More superficial than DLSO and generally easier to treat with topical agents.

Proximal subungual onychomycosis (PSO) – fungus enters from the proximal nail fold (the cuticle area) and spreads distally under the nail. Less common in immunocompetent individuals; when present, it raises suspicion for immunosuppression, particularly HIV. A proximal white patch under the nail that appears without obvious distal spread warrants HIV testing.

Total dystrophic onychomycosis – complete destruction of the nail plate, representing the end stage of severe longstanding infection. The entire nail becomes thickened, crumbling, and distorted.

Distinguishing Onychomycosis from Other Nail Conditions

Not every discoloured or thickened nail is a fungal infection – and treating a non-fungal condition with antifungals wastes time and money. Conditions that mimic onychomycosis:

This is why laboratory confirmation before prescribing oral antifungals is standard practice in most dermatology guidelines – treating empirically without confirmation risks treating the wrong condition.

Diagnosis: Confirmation Matters

Clinical diagnosis of onychomycosis is correct in only about 50-60% of cases when relying on appearance alone. Laboratory confirmation is important – particularly before starting oral antifungal treatment, which has potential side effects and is lengthy.

KOH (potassium hydroxide) microscopy: Nail clippings or subungual debris are dissolved in KOH and examined under a microscope for fungal hyphae. Fast (results within 30 minutes to hours), inexpensive, widely available. Sensitivity approximately 70-80% – a negative result doesn’t exclude infection.

Fungal culture: Nail material is cultured on specific media for several weeks. Identifies the causative organism and its antifungal sensitivities. More specific than KOH microscopy but slow (results take 3-6 weeks) and has false-negative rates due to sampling difficulty.

PCR (polymerase chain reaction): Increasingly available. Faster and more sensitive than culture. Identifies dermatophytes, yeasts, and moulds with high accuracy.

Nail biopsy with PAS stain: The most sensitive method – a section of nail plate is stained with periodic acid-Schiff stain that highlights fungal elements. Used when other methods are negative but clinical suspicion remains high.

The practical approach: KOH microscopy first (fast and cheap), culture if needed for species identification or when treatment planning requires it, PCR where available.

Treatment: Why It’s Difficult

Nail infections are inherently difficult to treat because:

1. The nail plate is a dense keratin barrier with poor drug penetration
2. The target organisms are embedded in nail keratin where blood-borne drugs reach slowly
3. Nails grow slowly – even after the infection is cleared, the damaged nail must grow out before the nail looks normal
4. Re-infection is common, particularly if underlying risk factors (athlete’s foot, hyperhidrosis, shared facilities) aren’t addressed

Topical Antifungals

Topical treatments have poor penetration through the nail plate to the nail bed where infection resides. They’re most appropriate for:

• White superficial onychomycosis (superficial, accessible to topical agents)
• Distal DLSO affecting less than 50% of one or two nails
• Patients who cannot take oral antifungals

Amorolfine nail lacquer (Loceryl): Widely used in Europe, Asia, and Australia. Applied weekly to affected nails. 6-month course for fingernails, 9-12 months for toenails. Mycological cure rates approximately 40-50% for mild DLSO. Available OTC in many countries.

Ciclopirox nail lacquer (Penlac): Applied daily, requires removal weekly. Lower cure rates than amorolfine in most comparative studies. Available by prescription in many countries.

Tavaborole solution (Kerydin) and efinaconazole solution (Jublia): Newer topical agents with improved nail penetration. Higher cure rates than older topical agents (complete cure rates approximately 15-18% in trials) but still lower than oral treatment. More expensive.

Oral Antifungals – The Most Effective Option

For moderate-to-severe onychomycosis, oral antifungals produce significantly higher cure rates than topical treatments.

Terbinafine (Lamisil): First-line oral treatment for dermatophyte onychomycosis. Allylamine class. Highly effective against dermatophytes. Standard regimen: 250mg daily for 6 weeks (fingernails) or 12 weeks (toenails). Mycological cure rates 70-80% for toenail dermatophyte infection. Generally well-tolerated. Liver toxicity is rare but requires baseline LFT in high-risk patients. Drug interactions via CYP2D6.

Itraconazole (Sporanox): Azole antifungal effective against dermatophytes, yeasts, and some moulds – broader spectrum than terbinafine. Used as continuous therapy (200mg daily for 3 months) or pulse therapy (400mg daily for 1 week per month for 3-4 months). Pulse therapy reduces side effect burden. More drug interactions than terbinafine (CYP3A4 interactions). Not suitable for patients with heart failure.

Fluconazole: Less commonly used for onychomycosis than terbinafine or itraconazole. Weekly dosing (150-300mg once weekly) for several months. Useful for Candida nail infections.

The recurrence problem: Even after successful treatment, recurrence rates within 3-5 years are 20-50%. This underscores the importance of addressing predisposing factors (treating concurrent athlete’s foot, maintaining foot hygiene, antifungal foot powder in shoes) alongside active treatment.

Laser Treatment

Several laser and light-based devices have been investigated for onychomycosis. Evidence is mixed – some studies show temporary improvement but cure rates are generally lower than oral antifungals and results are not durable. Not recommended as primary treatment in most dermatology guidelines, but may be an option for patients who can’t take oral antifungals.

Nail Avulsion

Chemical or surgical removal of the nail can be used alongside antifungal treatment for severely affected nails – removing infected material and improving drug penetration. Generally reserved for severe, treatment-resistant cases.

Prevention: What Actually Reduces Risk

• Treat athlete’s foot (tinea pedis) promptly – it’s the primary source of toenail infection
• Keep feet clean and dry; dry between the toes after bathing
• Wear moisture-wicking socks; change socks daily
• Wear protective footwear (sandals or flip-flops) in communal showers, pools, and locker rooms
• Trim nails straight across, keeping them short
• Avoid tight, occlusive footwear for prolonged periods
• Use antifungal foot powder in shoes if prone to sweaty feet
• Don’t share nail clippers, files, or footwear
• After successful treatment, consider weekly amorolfine lacquer as maintenance to reduce recurrence

Frequently Asked Questions

Can I treat fungal nail infection with home remedies like tea tree oil or vinegar? Some evidence exists for tea tree oil having antifungal properties in laboratory settings. Clinical evidence for nail infection treatment is very limited – small studies show modest effects at best. Vinegar soaks are widely used but have no meaningful clinical trial evidence for onychomycosis. These remedies may be appropriate for very mild superficial infections as adjuncts but should not substitute for evidence-based treatment in established nail infection.

How long until my nail looks normal after treatment? Even after the fungus is successfully eliminated, the damaged nail must grow out before the nail appears normal. Toenails grow approximately 1-1.5mm per month – a full toenail takes 12-18 months to grow out completely. Fingernails grow faster (3-4mm per month) and take 4-6 months. This means that even with successful treatment, the nail won’t look normal for many months after completing the antifungal course.

Is onychomycosis dangerous if left untreated? For most healthy adults, untreated onychomycosis is uncomfortable and unsightly but not dangerous. However, in people with diabetes, peripheral vascular disease, or immunosuppression, untreated nail infection can be a source of recurrent bacterial skin infections, cellulitis, and entry points for more serious infection. In these populations, treatment is particularly important.

Can nail salons cause or spread fungal nail infection? Yes – improperly sterilized nail salon equipment (clippers, files, cuticle tools) can transmit fungal organisms between clients. Choosing salons that use properly autoclaved instruments or bringing your own is sensible precaution. Artificial nails and gel overlays can also trap moisture under the nail, promoting fungal growth.

Will antifungal nail polish work? Cosmetic nail polishes are not antifungal. Medicated antifungal nail lacquers (amorolfine, ciclopirox) are different products available from pharmacies – these are treatment products, not cosmetics. Applying regular nail polish over an infected nail traps moisture and can worsen the infection.

Disclaimer

This article is for educational purposes only and does not constitute medical advice. Nail conditions that appear to be fungal infections should be confirmed by laboratory testing before starting treatment, particularly oral antifungal medication. Consult a qualified healthcare provider or dermatologist for diagnosis and treatment planning.

References

1. Gupta AK, Stec N, Summerbell RC, et al. Onychomycosis: a review. Journal of the European Academy of Dermatology and Venereology. 2020;34(9):1972-1990. https://doi.org/10.1111/jdv.16394
2. Nenoff P, Verma SB, Vasani R, et al. The current European position on the diagnosis of onychomycosis. Mycoses. 2019;62(1):4-17. https://doi.org/10.1111/myc.12827
3. Elewski BE, Rich P, Pollak R, et al. Efinaconazole 10% solution in the treatment of toenail onychomycosis. Journal of the American Academy of Dermatology. 2013;68(4):600-608. https://doi.org/10.1016/j.jaad.2012.10.013
4. Rotta I, Sanchez A, Gonçalves PR, et al. Efficacy and safety of topical antifungals in the treatment of dermatomycosis: a systematic review. British Journal of Dermatology. 2012;166(5):927-933. https://doi.org/10.1111/j.1365-2133.2012.10820.x
5. World Health Organization (WHO). Fungal diseases. https://www.who.int/news-room/fact-sheets/detail/fungal-diseases
6. British Association of Dermatologists. Guidelines for the management of onychomycosis. British Journal of Dermatology. 2014;171(5):937-958. https://doi.org/10.1111/bjd.13358
7. Piraccini BM, Alessandrini A. Onychomycosis: a review. Journal of Fungi. 2015;1(1):30-43. https://doi.org/10.3390/jof1010030
8. Hay RJ. Onychomycosis. Journal of Infection. 2011;62(6):414-420. https://doi.org/10.1016/j.jinf.2011.03.014
9. MedlinePlus. Fungal nail infections. https://medlineplus.gov/fungalnailinfections.html
10. Verma S, Hay RJ. Topical therapy for onychomycosis: an update. Expert Opinion on Pharmacotherapy. 2020;21(9):1061-1070. https://doi.org/10.1080/14656566.2020.1742313